Built Environment Factors Linked to Prevalence of Coronary Heart Disease
By Elana Gotkine HealthDay Reporter
FRIDAY, March 29, 2024 -- The prevalence of coronary heart disease (CHD) is associated with built environment factors, according to a study published online March 28 in the European Heart Journal.
Zhuo Chen, Ph.D., from the Harrington Heart and Vascular Institute in Cleveland, and colleagues examined the association between machine vision-based built environment, measured using features extracted from Google Street View (GSV), and the prevalence of CHD. Health outcomes were predicted using convolutional neural networks, linear mixed-effects models, and activation maps. A total of 0.53 million GSV images covering 789 census tracts in seven U.S. cities were obtained.
The researchers found that 63 percent of the census tract variation in CHD prevalence was predicted by built environment features extracted from GSV using deep learning. A model that only included census tract-level age, sex, race, income, and education or composite indices of social determinants of health was improved with the addition of GSV features. A set of neighborhood features represented by buildings and roads associated with CHD prevalence was revealed by activation maps from the features.
"Our study carries significant implications for the field of health research clinical practice," the authors write. "Firstly, we have pioneered the utilization of street view features in assessing cardiovascular risk, marking a novel approach that introduces new dimensions to our comprehension of the impact of the built environment on health."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.